The human V3 pituitary vasopressin receptor: Ligand binding profile and density-dependent signaling pathways

Endocrinology

Volumn 138, Issue 10, 1997, Pages 4109-4122

  Thibonnier, Marc ^a   Preston, Judy A ^a   Dulin, Nickolai ^a   Wilkins, Pamela L ^a   Berti Mattera, Liliana N ^a   Mattera, Rafael ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN V3 RECEPTOR; ARACHIDONIC ACID; BORDETELLA VIRULENCE FACTOR; CYCLIC AMP; DNA; LIGAND; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; THYMIDINE; TRITIUM; VASOPRESSIN RECEPTOR;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CHO CELL; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; ANIMAL; CELL DIVISION; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; FEMALE; GENETICS; HAMSTER; HUMAN; HYPOPHYSIS; METABOLISM; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING;

ANIMALS; ARACHIDONIC ACID; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CHO CELLS; CRICETINAE; CYCLIC AMP; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIGANDS; PERTUSSIS TOXIN; PHENOTYPE; PHOSPHOLIPASE C; PHOSPHORYLATION; PITUITARY GLAND; PROTEIN BINDING; PROTEIN KINASE C; RECEPTORS, VASOPRESSIN; SIGNAL TRANSDUCTION; THYMIDINE; TRITIUM; VIRULENCE FACTORS, BORDETELLA;

EID: 85047680820     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.10.5432     Document Type: Article

References (56)

1. 1-vascular vasopressin receptors. Regul Pept 45:79-84
2. Michell RH, Kirk JC, MMB 1979 Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans 7:861-865
3. Antoni F 1984 Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology 39:186-188
4. Baertschi AJ, Friedli M 1985 A novel type of vasopressin receptor on anterior pituitary corticotrophs? Endocrinology 116:499-502
5. Arsenijevic Y, Dubois-Dauphin M, Tribollet E, Manning M, Sawyer WH, Dreifuss JJ 1994 Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe. J Endocrinol 141:383-391
6. Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, Sawyer WH 1986 Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 30:171-177
7. 3-pituitary vasopressin receptor. FEBS Lett 356:215-220
8. Dahia PLM, Ahmed-Shuaib A, Jacobs RA, Chew SL, Honegger J, Fahlbusch R, Besser GM, Grossman AB 1996 Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. J Clin Endocrinol Metab 81:1768-1771
9. De Keyser Y, Lenne F, Auzan C, Jégou S, René P, Vaudry H, Kuhn JM, Luton JP, Clauser E, Bertagna X 1996 The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 97:1311-1318
10. Aguilera G 1994 Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15:321-350
11. Giguere V, Labrie F 1982 Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-release factor in rat anterior pituitary cells in culture. Endocrinology 111:1752-1754
12. Knepel W, Homolka L, Vlakovska M, Nutto D 1984 In vitro adrenocorticotropin/β-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity. Neuroendocrinology 38:344-350
13. ++ responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and arginine vasopressin in pituitary corticotroph and somatotroph adenomas. Clin Endocrinol (Oxf) 33:73-79
14. Liu JP 1994 Studies of the mechanisms of action of corticotropin-releasing factor (CRF) and vasopressin (AVP) in the ovine anterior pituitary: evidence that CRF and AVP stimulate protein phosphorylation and dephosphorylation. Mol Cell Endocrinol 106:57-66
15. Liu JP, Engler D, Funder JW, Robinson PJ 1994 Arginine vasopressin (AVP) causes the reversible phosphorylation of the myristoylated alanine-rich C kinase substrate (MARCKS) protein in the ovine anterior pituitary: evidence that MARCKS phosphorylation is associated with adrenocorticotropin (ACTH) secretion. Mol Cell Endocrinol 105:217-226
16. Holmes MC, Antoni FA, Szentendrei T 1984 Pituitary receptors for corticotropin-releasing factor: no effect of vasopressin on binding or activation of adenylate cyclase. Neuroendocrinology 39:162-169
17. 1a vasopressin receptor. J Biol Chem 269:3304-3310
18. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P, Rosenthal W 1992 Molecular cloning of the receptor for human antidiuretic hormone. Nature 357:333-335
19. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H 1992 Structure and expression of a human oxytocin receptor. Nature 356:526-529
20. 1a arginine vasopressin receptor. Nature 356:523-526
21. 2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339
22. 2-adrenergic receptor. Biochem Biophys Res Commun 150:665-672
23. s-coupled receptors and dependent on receptor density. Mol Pharmacol 46:460-469
24. Birnbaumer M 1995 Mutations and diseases of G protein coupled receptors. J Recept Signal Transduction Res 15:131-160
25. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, Schultz G 1996 The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA 93:116-120
26. Malerbi DA, Mendonça BB, Liberman B 1993 The desmopressin stimulation test in the differential diagnosis of Cushing's disease. Clin Endocrinol (Oxf) 38:463-472
27. Thibonnier M, Bayer AL, Madhun Z, Linear V 1993 1-Vascular vasopressin antagonists suitable for radioiodination, biotinylation, and fluorescent labeling. Am J Physiol 265:E906-E913
28. 3H]QNB binding and contraction in vitro. J Appl Physiol 52:1084-1091
29. Thibonnier M, Roberts JM 1985 Characterization of human platelet vasopressin receptors. J Clin Invest 76:1857-1864
30. Griffin HD, JNH 1978 Calcium-activated hydrolysis of phosphatidyl-myo-inositol 4-phosphate and phosphatidyl-myo-inositol 4,5-biphosphate in guinea-pig synaptosomes. Biochem J 176:541-552
31. Evans T, Smith MM, Tanner LI, Harden TK 1984 Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms. Mol Pharmacol 26:395-404
32. Bihoreau C, Monnot C, Davies E, Teutsch B, Bernstein K, Corvol P, Clauser E 1993 Asp74 mutations of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G protein coupling. Proc Natl Acad Sci USA 90:5133-5137
33. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H 1994 Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 269:27088-27092
34. Liard JF 1994 L-NAME antagonizes vasopressin V2-induced vasodilation in dogs. Am J Physiol 266:H99-H106
35. 1a receptors. Neuroendocrinology 62:135-146
36. 11 proteins in transfected Cos-7 cells. J Biol Chem 267:1811-1817
37. 32P]gamma-azidoanilido GTP in response to vasopressin. J Biol Chem 266:11409-11412
38. 1-vascular vasopressin receptors. Am J Physiol 264:C1336-C1344
39. Phaneuf S, Carrasco MP, Europe-Finner GN, Hamilton C, Lopez-Bernal A 1986 Multiple G proteins, and phospholipase C isoforms in human myometrial cells: implication for oxytocin action. J Clin Endocrinol Metab 81:2098-2103
40. s-cAMP-mediated inhibition. J Biol Chem 270:25259-25265
41. Liu J, Wess J 1996 Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family. J Biol Chem 271:8772-8778
42. Wong SKF, Ross EM 1994 Chimeric muscarinic cholinergic:β-adrenergic receptors that are functionally promiscuous among G proteins. J Biol Chem 269:18968-18976
43. Hawes BE, VanBiesen T, Koch WJ, Luttrell LM, Lefkowitz RJ 1995 Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J Biol Chem 270:17148-17153
44. Faure M, Voyno-Yasenetskaya TA, Bourne HR 1994 cAMP, and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269:7851-7854
45. Granot Y, Erikson E, Fridman H, Van Putten V, Williams B, Schrier R, Maller JL 1993 Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured rat vascular smooth muscle cells. J Biol Chem 268:9564-9569
46. Nishioka N, Hirai S, Mizuno K, Osada S, Suzuki A, Kosaka K, Ohno S 1995 Wortmannin inhibits the activation of MAP kinase following vasopressin V1 receptor stimulation. FEBS Lett 377:393-398
47. Ohmichi M, Koike K, Nohara A, Kanda Y, Sakamoto Y, Zhang ZX, Hirota K, Miyake A 1995 Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology 136:2082-2087
48. 2-mediated arachidonic acid release independent of calcium and mitogen-activated protein kinase regulation. J Biol Chem 269:1889-1895
49. Liao DF, Duff JL, Daum G, Pelech SL, Berk BC 1996 Angiotensin II stimulates MAP kinase activity in vascular smooth muscle cells. Role of raf. Circ Res 79:1007-1014
50. Dikic I, Schlessinger J, Lax I 1994 PC12 cells overxpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr Biol 4:702-708
51. Jin WD, Boutillier AL, Glucksman MJ, Salton SRJ, Loeffler JP, Roberts JL 1994 Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein. Mol Endocrinol 8:1377-1388
52. Rizzo MT, Carlo-Stella C 1996 Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stroma cells. Blood 88:3792-3800
53. Mischak H, Seitz T, Janosch P, Eulitz M, Steen H, Schellerer M, Philipp A, Kolch W 1996 Negative regulation of Raf-1 by phosphorylation of serine 621. Mol Cell Endocrinol 16:5409-5418
54. Van Biesen T, Luttrell LM, Hawes BE, Lefkowitz RJ 1996 Mitogenic signaling via G protein-coupled receptors. Endocr Rev 17:698-714
55. Kaiser UB, Conn PM, Chin WW 1997 Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocr Rev 18:46-70
56. Calleja V, Enriquez PR, Filloux C, Peraldi P, Baron V, Van Obberghen E 1997 The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor. Endocrinology 138:1111-1120